HealthEquity (NASDAQ:HQY) Stock Price Down 5.3% – Should You Sell?

HealthEquity, Inc. (NASDAQ:HQY) fell 5.3% during mid-day trading on Tuesday . The stock traded as low as $94.25 and last traded at $95.67. 211,317 shares were traded during trading, a decline of 66% from the average session volume of 625,859 shares. The stock had previously closed at $101.00.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft raised their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Barrington Research lifted their price target on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Monday, December 2nd. JMP Securities boosted their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday. The Goldman Sachs Group initiated coverage on shares of HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective for the company. Finally, Mizuho began coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price on the stock. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $110.71.

HealthEquity Trading Up 2.1 %

The firm’s 50 day simple moving average is $93.48 and its 200-day simple moving average is $84.00. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $8.50 billion, a PE ratio of 81.13, a P/E/G ratio of 1.57 and a beta of 0.55.

Insiders Place Their Bets

In other HealthEquity news, Director Frank Corvino sold 1,039 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the sale, the director now directly owns 3,784 shares of the company’s stock, valued at $363,642.40. This trade represents a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $101.56, for a total transaction of $837,870.00. Following the completion of the sale, the director now owns 66,469 shares in the company, valued at $6,750,591.64. The trade was a 11.04 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 18,786 shares of company stock worth $1,722,387 in the last 90 days. 2.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in HQY. CWM LLC raised its stake in HealthEquity by 6.9% during the 2nd quarter. CWM LLC now owns 3,958 shares of the company’s stock valued at $341,000 after purchasing an additional 255 shares during the period. SG Americas Securities LLC increased its position in HealthEquity by 48.5% in the 2nd quarter. SG Americas Securities LLC now owns 3,798 shares of the company’s stock worth $327,000 after buying an additional 1,241 shares during the period. Wealth Enhancement Advisory Services LLC acquired a new position in HealthEquity during the 2nd quarter valued at $265,000. Gradient Investments LLC grew its position in HealthEquity by 2.3% during the second quarter. Gradient Investments LLC now owns 54,849 shares of the company’s stock worth $4,728,000 after buying an additional 1,218 shares in the last quarter. Finally, Raymond James & Associates increased its position in shares of HealthEquity by 11.3% during the second quarter. Raymond James & Associates now owns 149,407 shares of the company’s stock valued at $12,879,000 after purchasing an additional 15,140 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.